Medicine and Dentistry
Injury
100%
Traumatic Brain Injury
94%
Thrombocyte Dysfunction
30%
Coagulopathy
22%
Brain Injury
20%
Thrombocyte Function
19%
Blood Brain Barrier
19%
Tranexamic Acid
19%
Resuscitation
18%
Bleeding
16%
Thrombocyte Aggregation
15%
Adenosine Diphosphate
15%
Deep Vein Thrombosis
13%
Laparotomy
13%
Triage
13%
Biological Marker
13%
Leukocyte
12%
Polytrauma
12%
Surgeon
11%
Limb Injury
11%
Hypoxia
10%
Neurologic Examination
10%
Platelet
10%
Blood Vessel Injury
9%
Receptor
9%
Elderly Patient
9%
Critical Illness
9%
Rib Fracture
9%
Opiate
9%
Thorax Surgery
9%
Cholecystectomy
9%
Angiography
9%
Drug Therapy
9%
Evacuation
9%
Breast Cancer
9%
Pericardial Fluid
9%
Nervous System Injury
9%
Exploratory Laparotomy
9%
Acute Lung Injury
9%
Abdominal Injury
9%
Ubiquitin Thiolesterase
9%
Erythrocyte
9%
Geriatrics
9%
Delirium
9%
Thromboelastography
8%
Venous Thromboembolism
6%
Pulmonary Embolism
6%
Shock (Circulatory)
6%
Hemorrhagic Shock
5%
Blood Product
5%
Keyphrases
Traumatic Brain Injury
97%
Platelet Dysfunction
30%
Trauma
26%
Murine Model
22%
Coagulopathy
22%
Traumatic Injury
21%
Duplex Ultrasound
19%
Ultrasound Screening
19%
Lower Extremity
19%
Acid Sphingomyelinase
19%
Tranexamic Acid
19%
Coagulation
15%
Sham
15%
Risk Index
14%
Platelet Aggregation
14%
Transfusion Requirements
13%
Transfusion
13%
Trauma Patients
12%
Platelet Function
12%
Massive Transfusion
11%
Blood-brain Barrier
11%
Trauma Center
11%
Mild Traumatic Brain Injury (mTBI)
11%
Screening Protocol
11%
Resuscitation
11%
High Risk
11%
Polytrauma
10%
Extremity Injury
10%
Laparotomy
10%
Blood-brain Barrier Permeability
10%
Neurological Examination
10%
Hemorrhagic Pericardial Effusion
9%
Brain Injury Guidelines
9%
Completion Angiography
9%
Fluid Administration
9%
Exploratory Laparotomy
9%
Pressure Regulator
9%
Intrathoracic Pressure Regulation
9%
Regulator Performance
9%
Natural Antimicrobials
9%
Open Abdomen
9%
Laparoscopic Subtotal Cholecystectomy
9%
Crystalloid
9%
Host Defense
9%
Abdominal Trauma
9%
Novel Therapeutics
9%
Sphingosine
9%
Rib Fixation
9%
Critical Illness
9%
Antimicrobial Therapeutics
9%
